We are live on ! Find out more
IMVT icon

Immunovant
IMVT

118 hedge funds and large institutions have $322M invested in Immunovant in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,952% more call options, than puts

Call options by funds: $22.9M | Put options by funds: $1.12M

10% more capital invested

Capital invested by funds: $293M → $322M (+$28.1M)

3.53% more ownership

Funds ownership: 29.38% → 32.91% (+3.5%)

5% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 20

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 119 → 118 (-1)

11% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 45

Holders
118
Holders Change
-1
Holders Change %
-0.84%
% of All Funds
1.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
40
Reduced
45
Closed
20
Calls
$22.9M
Puts
$1.12M
Net Calls
+$21.8M
Net Calls Change
-$22.6M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$7.43M
2
OCA
Octagon Capital Advisors
New York
+$4.73M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$4.02M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.18M
5
PAMP
Polar Asset Management Partners
Ontario, Canada
+$1.96M

Top Sellers

1
State Street
State Street
Massachusetts
-$11M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$3.65M
3
Morgan Stanley
Morgan Stanley
New York
-$3.04M
4
Two Sigma Investments
Two Sigma Investments
New York
-$2.4M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$2.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Eventide Asset Management
Massachusetts
$42.2M – – –
DTC
2
Deep Track Capital
Connecticut
$40.7M +$39.4M +4,775,000 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$32.7M +$700K +84,833 +2%
BlackRock
4
BlackRock
New York
$28.3M +$627K +76,000 +2%
AGM
5
Alpine Global Management
New York
$25.6M +$56.1K +6,800 +0.2%
State Street
6
State Street
Massachusetts
$23.7M -$11M -1,329,000 -32%
EC
7
EcoR1 Capital
California
$9.72M – – –
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$7.67M +$7.43M +900,500 New
Two Sigma Investments
9
Two Sigma Investments
New York
$7.27M -$2.4M -290,783 -25%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$6.99M -$293K -35,509 -4%
Two Sigma Advisers
11
Two Sigma Advisers
New York
$6.24M -$2.28M -276,200 -27%
MP
12
Mangrove Partners
Connecticut
$5.86M +$1.55M +188,000 +38%
PIM
13
Platinum Investment Management
Australia
$5.25M +$502K +60,835 +11%
FM
14
Frazier Management
Washington
$4.99M – – –
OCA
15
Octagon Capital Advisors
New York
$4.88M +$4.73M +572,862 New
Federated Hermes
16
Federated Hermes
Pennsylvania
$4.26M +$4.02M +486,456 +3,732%
Morgan Stanley
17
Morgan Stanley
New York
$4.23M -$3.04M -368,336 -43%
Northern Trust
18
Northern Trust
Illinois
$3.32M -$13.6K -1,649 -0.4%
N
19
Nuveen
North Carolina
$3.17M +$104K +12,643 +4%
PAMP
20
Polar Asset Management Partners
Ontario, Canada
$2.97M +$1.96M +237,600 +214%
Millennium Management
21
Millennium Management
New York
$2.88M +$1.07M +130,042 +63%
Goldman Sachs
22
Goldman Sachs
New York
$2.5M -$1.36M -165,124 -36%
Charles Schwab
23
Charles Schwab
California
$2.48M +$178K +21,554 +8%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$2.37M +$2.18M +264,230 +1,923%
Citadel Advisors
25
Citadel Advisors
Florida
$2.11M +$652K +79,018 +47%
1
2 3 4 5

IMVT Hedge Fund Activity: Q4 2021 in Review

118 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q4 2021, worth a combined $322M — up 9.6% from $293M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new IMVT positions and 20 closed out — a net gain of 1 holder — while 40 added to existing stakes and 45 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $7.43M. The largest seller was State Street, cutting an estimated $11M.

  • 118 institutional investors held Immunovant (IMVT) as of Q4 2021, down from 119 in Q3 2021.
  • Funds reported $322M of Immunovant stock for Q4 2021, up 9.6% quarter-over-quarter.
  • 21 funds opened new Immunovant positions in Q4 2021 and 20 closed out, a net change of +1 holder.
  • The largest Immunovant buyer in Q4 2021 was Point72 Asset Management, an estimated $7.43M added.
  • The largest Immunovant seller in Q4 2021 was State Street, an estimated $11M sold.

Based on aggregated 13F filings for Q4 2021.